News Detail
New Delhi, 31 Jan 2023: The Department of Biotechnology (DBT) has initiated efforts to support research and development of affordable and effective therapies to reduce the incidence of cancer in the country, with an aim to make the nation cancer free by 2047.
The Depar......
View Details
Source : Pharmabiz
Department of Biotechnology
. DBT
cancer
Letter of Intent
LoI
Cancer Disease Biology Research
DBT
Cancer Free India
DSIR
SIRO
eProMIS
EY India
FICCI
Call for Actoin
Related News
- Zydus gets warning as FDA highlights glass contamination concerns and others (12-09-2024)
- MPIDC allotted land to 36 industries in Medical Devices Park, investment of 1.8k crore (12-09-2024)
- DCC asks states and UTs to ensure implementation of revised Schedule M (12-09-2024)
- NPPA fixes retail price of 62 new drugs, extends CP of knee implants (12-09-2024)
- US FDA Issues Revised Guidance On Controlling Nitrosamine Impurities In Pharmaceuticals (12-09-2024)
- Bharat Biotech collaborates with US-based Alopexx to develop antimicrobial vaccine (12-09-2024)
- DCGI suspends permission to Entod pharma's 'Presvu Eye Drops', company to challenge order in court (11-09-2024)
- Diagnostic kits for early detection of Alzheimer’s and cancer launched (11-09-2024)
- FDI equity inflow into pharma sector grows to $236 million in Q1FY25 (11-09-2024)
- Steroid Use Could Raise Diabetes Risk (11-09-2024)